[GASMSIA] QoQ Annualized Quarter Result on 30-Sep-2021 [#3]

Stock
[GASMSIA] GAS MALAYSIA BERHAD
Announcement Date
19-Nov-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Sep-2021 [#3]
Profit Trend
QoQ- 1.91%
YoY- 25.76%
Quarter Report
Latest QR
Upcoming QR
GASMSIA's Result
GASMSIA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 7,122,528 7,136,612 5,851,600 5,214,856 5,055,948 4,610,728 6,686,868 4.30%
PBT 528,802 481,300 330,398 317,842 309,902 288,476 290,843 49.13%
Tax -131,488 -116,032 -80,776 -77,402 -73,964 -65,956 -78,221 41.51%
NP 397,314 365,268 249,622 240,440 235,938 222,520 212,622 51.88%
-
NP to SH 397,314 365,268 249,622 240,440 235,938 222,520 212,622 51.88%
-
Tax Rate 24.87% 24.11% 24.45% 24.35% 23.87% 22.86% 26.89% -
Total Cost 6,725,214 6,771,344 5,601,978 4,974,416 4,820,010 4,388,208 6,474,246 2.57%
-
Net Worth 1,163,945 1,055,961 1,130,048 1,060,455 1,059,813 997,411 1,080,100 5.12%
Dividend
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Div 151,512 - 138,672 82,176 123,264 - 123,905 14.39%
Div Payout % 38.13% - 55.55% 34.18% 52.24% - 58.28% -
Equity
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Net Worth 1,163,945 1,055,961 1,130,048 1,060,455 1,059,813 997,411 1,080,100 5.12%
NOSH 1,284,000 1,284,000 1,284,000 1,284,000 1,284,000 1,284,000 1,284,000 0.00%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 5.58% 5.12% 4.27% 4.61% 4.67% 4.83% 3.18% -
ROE 34.14% 34.59% 22.09% 22.67% 22.26% 22.31% 19.69% -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 554.71 555.81 455.73 406.14 393.77 359.09 520.78 4.30%
EPS 30.94 28.44 19.44 18.72 18.38 17.32 16.56 51.86%
DPS 11.80 0.00 10.80 6.40 9.60 0.00 9.65 14.39%
NAPS 0.9065 0.8224 0.8801 0.8259 0.8254 0.7768 0.8412 5.12%
Adjusted Per Share Value based on latest NOSH - 1,284,000
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 554.71 555.81 455.73 406.14 393.77 359.09 520.78 4.30%
EPS 30.94 28.44 19.44 18.72 18.38 17.32 16.56 51.86%
DPS 11.80 0.00 10.80 6.40 9.60 0.00 9.65 14.39%
NAPS 0.9065 0.8224 0.8801 0.8259 0.8254 0.7768 0.8412 5.12%
Price Multiplier on Financial Quarter End Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 -
Price 3.01 2.71 2.65 2.74 2.67 2.68 2.72 -
P/RPS 0.54 0.49 0.58 0.67 0.68 0.75 0.52 2.55%
P/EPS 9.73 9.53 13.63 14.63 14.53 15.46 16.43 -29.54%
EY 10.28 10.50 7.34 6.83 6.88 6.47 6.09 41.90%
DY 3.92 0.00 4.08 2.34 3.60 0.00 3.55 6.85%
P/NAPS 3.32 3.30 3.01 3.32 3.23 3.45 3.23 1.85%
Price Multiplier on Announcement Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 18/08/22 12/05/22 16/02/22 19/11/21 17/08/21 05/05/21 26/02/21 -
Price 3.25 2.75 2.69 2.69 2.64 2.71 2.63 -
P/RPS 0.59 0.49 0.59 0.66 0.67 0.75 0.51 10.23%
P/EPS 10.50 9.67 13.84 14.37 14.37 15.64 15.88 -24.16%
EY 9.52 10.34 7.23 6.96 6.96 6.39 6.30 31.78%
DY 3.63 0.00 4.01 2.38 3.64 0.00 3.67 -0.72%
P/NAPS 3.59 3.34 3.06 3.26 3.20 3.49 3.13 9.59%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment